Antibodies Fall Dramatically in First 3 Months of Mild COVID-19
Previous reports have suggested that antibodies against the novel coronavirus are short-lived, but the rate at which they decrease has not been carefully defined
A study by University of California, Los Angeles (UCLA) researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2—the virus that causes the disease—drop sharply over the first three months after infection, decreasing by roughly half every 73 days. If sustained at that rate, the antibodies would disappear within about a year.
Background
Previous reports have suggested that antibodies against the novel coronavirus are short-lived, but the rate at which they decrease has not been carefully defined. This is the first study to carefully estimate the rate at which the antibodies disappear.
Method
The researchers studied 20 women and 14 men who recovered from mild cases of COVID-19. Antibody tests were conducted at an average of 36 days and 82 days after the initial symptoms of infection.
Impact
The findings raise concerns about antibody-based "immunity passports," the potential for herd immunity, and the reliability of antibody tests for estimating past infections. In addition, the findings may have implications for the durability of antibody-based vaccines.
- This press release was originally published on the UCLA Newsroom